These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [An analysis and literature review of two cases of autoimmune encephalitis with GABA Zhang M; Hao HJ; Liu LP; Zhang HH; Zhou YY Zhonghua Nei Ke Za Zhi; 2016 Oct; 55(10):791-793. PubMed ID: 27686441 [TBL] [Abstract][Full Text] [Related]
32. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy. Wright S; Geerts AT; Jol-van der Zijde CM; Jacobson L; Lang B; Waters P; van Tol MJ; Stroink H; Neuteboom RF; Brouwer OF; Vincent A Epilepsia; 2016 May; 57(5):823-31. PubMed ID: 26996997 [TBL] [Abstract][Full Text] [Related]
33. Utilization of APE2 and RITE2 scores in autoimmune encephalitis patients with seizures. Rafferty T; Koeppen-Babcock A; Muppidi S; Li Y; Le S Epilepsy Behav; 2024 May; 154():109737. PubMed ID: 38518672 [TBL] [Abstract][Full Text] [Related]
34. Antiglutamic acid decarboxylase antibodies in children with encephalitis and status epilepticus. Lin JJ; Lin KL; Hsia SH; Wang HS; Chou IJ; Lin YT; Pediatr Neurol; 2012 Oct; 47(4):252-8. PubMed ID: 22964438 [TBL] [Abstract][Full Text] [Related]
35. Postencephalitic epilepsy and drug-resistant epilepsy after infectious and antibody-associated encephalitis in childhood: Clinical and etiologic risk factors. Pillai SC; Mohammad SS; Hacohen Y; Tantsis E; Prelog K; Barnes EH; Gill D; Lim MJ; Brilot F; Vincent A; Dale RC Epilepsia; 2016 Jan; 57(1):e7-e11. PubMed ID: 26592968 [TBL] [Abstract][Full Text] [Related]
36. Progressive hearing loss and cerebellar ataxia in anti-Ma2-associated autoimmune encephalitis. Souza PV; Bortholin T; Pinto WB; Santos AJ Arq Neuropsiquiatr; 2017 Jan; 75(1):74-75. PubMed ID: 28099568 [No Abstract] [Full Text] [Related]
37. Epidemiology of Antibody-Positive Autoimmune Encephalitis in Southwest China: A Multicenter Study. Gu Y; Zhong M; He L; Li W; Huang Y; Liu J; Chen Y; Xiao Z Front Immunol; 2019; 10():2611. PubMed ID: 31781111 [TBL] [Abstract][Full Text] [Related]
38. Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies. McGinty RN; Handel A; Moloney T; Ramesh A; Fower A; Torzillo E; Kramer H; Howell S; Waters P; Adcock J; Sen A; Lang B; Irani SR J Neurol Neurosurg Psychiatry; 2021 Mar; 92(3):291-294. PubMed ID: 33219046 [TBL] [Abstract][Full Text] [Related]
39. Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis. Liu CY; Zhu J; Zheng XY; Ma C; Wang X Mediators Inflamm; 2017; 2017():6361479. PubMed ID: 28698711 [TBL] [Abstract][Full Text] [Related]
40. Autoimmune receptor encephalitis in mice induced by active immunization with conformationally stabilized holoreceptors. Jones BE; Tovar KR; Goehring A; Jalali-Yazdi F; Okada NJ; Gouaux E; Westbrook GL Sci Transl Med; 2019 Jul; 11(500):. PubMed ID: 31292262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]